Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 14, 2024 |
| Target | Catalent - Oral Solids Facility |
| Sector | Life Science |
| Buyer(s) | Ardena |
| Sellers(s) | Catalent |
| Deal Type | Divestiture |
FILTER BY
Ardena is a contract development and manufacturing organization (CDMO). Ardena offers an integrated, flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis, and dossier development. Ardena was founded in 1994 and is based in Ghent, Belgium.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Divestiture | 1 of 1 |
| State: New Jersey | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-03-16 |
ChemConnection BV
Oss, Netherlands ChemConnection BV is a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines. ChemConnection BV was founded in 2012 and is based in Oss, Netherlands. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
| Revenue | 4.3B USD (2023) |
Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.
| Deal Context for Seller | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 3 of 3 |
| Type: Divestiture | 3 of 3 |
| State: New Jersey | 1 of 1 |
| Country: United States | 3 of 3 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-09 |
Metrics Contract Services
Greenville, North Carolina, United States Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics provides formulation development, analytical testing, and commercial manufacturing from its single-campus facility in Greenville, North Carolina. |
Buy | $475M |
